EXDENSUR
Iraq – Federal (Baghdad) Opposition closed
Some details of this record were read from an image by OCR. Check them against the official bulletin.
| Notice | Application |
|---|---|
| Application no. | 100170 |
| Filing date | — |
| Owner | Glaxo Group Limited |
| Address | GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY , United Kingdom |
| Country | United Kingdom |
| Bulletin | No. 1462, first announced 11 Jun 2025, page 103 |
| Opposition deadline | 9 Sep 2025 (90 days from the last announcement; confirm with the office) |
| Official source | Open the official bulletin (PDF) |